Questionable efficacy of the rVSV-ZEBOV Ebola vaccine - Authors' reply
- PMID: 29565012
- DOI: 10.1016/S0140-6736(18)30559-2
Questionable efficacy of the rVSV-ZEBOV Ebola vaccine - Authors' reply
Comment on
-
Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!).Lancet. 2017 Feb 4;389(10068):505-518. doi: 10.1016/S0140-6736(16)32621-6. Epub 2016 Dec 23. Lancet. 2017. PMID: 28017403 Free PMC article. Clinical Trial.
Similar articles
-
Questionable efficacy of the rVSV-ZEBOV Ebola vaccine.Lancet. 2018 Mar 17;391(10125):1021. doi: 10.1016/S0140-6736(18)30560-9. Epub 2018 Mar 15. Lancet. 2018. PMID: 29565013 No abstract available.
-
Immunomonitoring of human responses to the rVSV-ZEBOV Ebola vaccine.Curr Opin Virol. 2017 Apr;23:88-94. doi: 10.1016/j.coviro.2017.03.008. Epub 2017 Apr 28. Curr Opin Virol. 2017. PMID: 28460340 Review.
-
Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial.Lancet. 2015 Aug 29;386(9996):857-66. doi: 10.1016/S0140-6736(15)61117-5. Epub 2015 Aug 3. Lancet. 2015. PMID: 26248676 Clinical Trial.
-
Circulating follicular T helper cells and cytokine profile in humans following vaccination with the rVSV-ZEBOV Ebola vaccine.Sci Rep. 2016 Jun 21;6:27944. doi: 10.1038/srep27944. Sci Rep. 2016. PMID: 27323685 Free PMC article.
-
Durability of single-dose rVSV-ZEBOV vaccine responses: what do we know?Expert Rev Vaccines. 2018 Dec;17(12):1105-1110. doi: 10.1080/14760584.2018.1546582. Epub 2018 Nov 15. Expert Rev Vaccines. 2018. PMID: 30422031 Review.
Cited by
-
Self-Amplifying RNA Viruses as RNA Vaccines.Int J Mol Sci. 2020 Jul 20;21(14):5130. doi: 10.3390/ijms21145130. Int J Mol Sci. 2020. PMID: 32698494 Free PMC article. Review.
-
Recombinant vesicular stomatitis virus vector vaccines for WHO blueprint priority pathogens.Hum Vaccin Immunother. 2019;15(10):2269-2285. doi: 10.1080/21645515.2019.1649532. Epub 2019 Sep 5. Hum Vaccin Immunother. 2019. PMID: 31368826 Free PMC article. Review.
-
Development and Applications of Viral Vectored Vaccines to Combat Zoonotic and Emerging Public Health Threats.Vaccines (Basel). 2020 Nov 13;8(4):680. doi: 10.3390/vaccines8040680. Vaccines (Basel). 2020. PMID: 33202961 Free PMC article. Review.
-
Inactivated Rabies Virus-Based Ebola Vaccine Preserved by Vaporization Is Heat-Stable and Immunogenic Against Ebola and Protects Against Rabies Challenge.J Infect Dis. 2019 Sep 26;220(9):1521-1528. doi: 10.1093/infdis/jiz332. J Infect Dis. 2019. PMID: 31374568 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical